CytRx Corp's (CYTR) Bafetinib Receives Positive Opinion from COMP of the EMEA
Tweet Send to a Friend
CytRx Corporation (Nasdaq: CYTR) today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
